Arkolith/Insider Trading/CNTA/Form 4

Accardi Mario Alberto

Chief Executive Officer, DirectorCentessa Pharmaceuticals plc (CNTA) · full profile →Form 4 · filed May 18, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2026Tax withholding(F)604$39.42$24K243K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-26-000463) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML